FDA Inspection 1153994 — Eyegaze Inc.

Eyegaze Inc. — FEI 1000123308

The FDA completed an inspection of Eyegaze Inc. on October 8, 2021 in Fairfax, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 8, 2021
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Fairfax, VA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
341521 CFR 820.22Quality Audit/Reaudit - conducted
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures